Aethlon Medical Navigates Turbulent Period with Capital Raise and Patent Developments

Aethlon Medical finds itself in a critical phase, with its shares experiencing significant volatility as the company undertakes essential measures to secure its operational future. The medical technology firm is actively working to stabilize its position through a recently announced capital infusion and the strengthening of its intellectual property portfolio.

In a move crucial for its ongoing research initiatives, Aethlon Medical secured financing through a public offering in early September. The company placed units, consisting of common stock and warrants, at $0.90 per unit. This transaction involved the issuance of 5 million shares of common stock alongside warrants to purchase up to an additional 5 million shares. Proceeds totaling $4.5 million are designated to support clinical trial programs, research and development activities, and general corporate... Read more...